huge achievement, great work PAB. PAT-DX1 has proven to be an...

huge achievement, great work PAB. PAT-DX1 has proven to be an exception to this rule and has shown activity against brain tumours in mouse models of glioblastoma and triple negative breast cancer brain metastases. The study data clearly illustrates how PAT-DX1 is able to achieve these outcomes, and
provides compelling evidence of an ENT2-mediated method of BBB penetration by PAT-DX1. The ability to explain PAT-DX1’s entirely new and highly effective mechanism of action supports our plans to advance to IND filing and commence clinical studies, together with enhancing partnering discussions.”